- Home
- Advocacy
- Latest News and Practice Data
- FDA approves groundbreaking Alzheimer disease test
A new test could be a game changer in diagnosing Alzheimer disease. The US FDA has approved the first in vitro diagnostic blood test to aid in identifying the condition.
Why it matters: The test provides a more accessible method for detecting Alzheimer disease.
Who it's for: Adults aged 55 years and older who are showing signs or symptoms.
The Lumipulse G test detects amyloid plaques associated with Alzheimer disease using chemiluminescent enzyme immunoassay technology. This method offers high sensitivity and precision in biomarker quantification.
Go Deeper: Read the full FDA announcement.